LIGAND PHARMACEUTICALS INCORPORATED: revenue
| Value | {"amount": 141102000, "concept": "us-gaap:Revenues", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-09-01T13:00:39.512948+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a00b2254-af69-4a10-83a6-509ed4d9db81
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000886163-18-000030Retrieved: 2026-09-01T13:00:39.512948+02:00
Raw response sha256:
26b9f549d8d5fedfcc22ffc2cb401b4a…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/revenue/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a00b2254-af69-4a10-83a6-509ed4d9db81
History
- supersedes {"amount": 141102000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0000886163-19-000041)